Portfolio Diversification
Range
Most Diversified
20 instruments
January 1, 2022
Least Diversified
0 instruments
February 2, 2025
Average
19.7 instruments
Most Consistent Holdings
Top 5
JNJ99.91%
MRK99.91%
PFE99.91%
MRNA99.91%
NVAX99.91%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Number of Instruments
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Vaxcyte (PCVX) | 7.03% | 3.06% | 99.49% | - |
| Merck (MRK) | 6.69% | 5.94% | 99.91% | - |
 Arcturus Therapeutics (ARCT) | 6.25% | 4.97% | 99.91% | - |
| Novavax (NVAX) | 6.05% | 5.1% | 99.91% | - |
| Moderna (MRNA) | 5.99% | 4.2% | 99.91% | - |
 Dynavax (DVAX) | 5.58% | 5.65% | 99.91% | - |
 Sanofi (SNY) | 5.48% | 5.55% | 99.49% | - |
| Johnson & Johnson (JNJ) | 5.39% | 7.82% | 99.91% | - |
 Vir (VIR) | 5.07% | 3.75% | 99.91% | - |
 BioNTech SE (BNTX) | 4.81% | 6.96% | 99.91% | - |
| Pfizer (PFE) | 4.7% | 4.78% | 99.91% | - |
 Abbott (ABT) | 3.99% | 7.15% | 70.31% | - |
 CureVac (CVAC) | 3.89% | 4.68% | 99.91% | - |
 AstraZeneca (AZN) | 3.6% | 6.17% | 70.31% | - |
 Agenus (AGEN) | 3.43% | 0% | 90.87% | 1/2/2025 |
 GlaxoSmithKline (GSK) | 2.99% | 0% | 59.04% | 12/28/2023 |
 Emergent BioSolutions (EBS) | 2.49% | 2.42% | 68.52% | - |
 Maravai (MRVI) | 2.24% | 2.18% | 40.44% | - |
 Vaxart (VXRT) | 1.97% | 2.55% | 38.65% | - |
 Inovio (INO) | 1.62% | 0% | 59.47% | 12/28/2023 |
 CanSino Biologics (6185.HK) | 1.49% | 0% | 31.74% | 1/2/2025 |
 Valneva (VLA.PA) | 1.4% | 6.98% | 40.87% | - |
 CSL (CSL.ASX) | 1.23% | 0% | 31.31% | 1/1/2025 |
 Takeda (TAK) | 1.13% | 0% | 29.86% | 12/28/2023 |
 OPKO Health (OPK) | 1.05% | 0% | 31.4% | 1/2/2025 |
 Allovir (KLRS) | 0.88% | 0% | 29.61% | 1/5/2023 |
 Invivyd (IVVD) | 0.83% | 0% | 29.18% | 1/5/2023 |
 VBI Vaccines (VBIVQ) | 0.76% | 0% | 29.61% | 1/5/2023 |
 Bavarian Nordic A/S (BAVA.CO) | 0.38% | 4.42% | 9.04% | - |
 Personalis (PSNL) | 0.33% | 3.16% | 9.04% | - |
 GSK (GSK.L) | 0.02% | 0% | 0.43% | 1/5/2022 |
 Sanofi (SAN.PA) | 0.02% | 0% | 0.43% | 1/5/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Vaxcyte (PCVX) | 1.88% | 9.9% |
| Novavax (NVAX) | 15.45% | 8.86% |
| CanSino Biologics (6185.HK) | 3.53% | 7.58% |
| BioNTech SE (BNTX) | 6.83% | 6.35% |
| Abbott (ABT) | 3.67% | 5.93% |
| Merck (MRK) | 2.91% | 5.78% |
| Johnson & Johnson (JNJ) | 4.28% | 5.67% |
| AstraZeneca (AZN) | 3.35% | 5.01% |
| Dynavax (DVAX) | 2.91% | 4.91% |
| Maravai (MRVI) | 3.73% | 4.85% |
| Sanofi (SNY) | 2.87% | 4.38% |
| Pfizer (PFE) | 5.25% | 4.34% |
| Vir (VIR) | 7.69% | 4.3% |
| CSL (CSL.ASX) | 2.69% | 4.19% |
| OPKO Health (OPK) | 2.73% | 4.05% |
| CureVac (CVAC) | 8.22% | 3.88% |
| Arcturus Therapeutics (ARCT) | 3.58% | 3.83% |
| Moderna (MRNA) | 7.03% | 2.14% |
| Valneva (VLA.PA) | 2.71% | 2.1% |
| Agenus (AGEN) | 8.06% | 0.95% |